Pluri Inc. Shares Issued, Price Per Share
Pluri Inc. (PLUR) had Shares Issued, Price Per Share of $1.00 per share as of 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:SharesIssuedPricePerShare · last filed 2024-09-18
- 2023-03-31: Shares Issued, Price Per Share $1.00.
- 2022-12-27: Shares Issued, Price Per Share $8.96; Shares Issued, Price Per Share as first filed $1.12.
- 2022-12-19: Shares Issued, Price Per Share $8.72; Shares Issued, Price Per Share as first filed $1.09.
- 2022-12-15: Shares Issued, Price Per Share $8.48; Shares Issued, Price Per Share as first filed $1.06.
| Period end | Shares Issued, Price Per Share | Shares Issued, Price Per Share as first filed |
|---|---|---|
| 2023-03-31 | $1.00 10-Q · filed 2023-05-09 | |
| 2022-12-27 | $8.96 10-K · filed 2024-09-18 | $1.12 10-Q · filed 2024-02-12 |
| 2022-12-19 | $8.72 10-K · filed 2024-09-18 | $1.09 10-Q · filed 2024-02-12 |
| 2022-12-15 | $8.48 10-K · filed 2024-09-18 | $1.06 10-Q · filed 2024-02-12 |
| 2022-12-14 | $8.40 10-K · filed 2024-09-18 | $1.05 10-Q · filed 2024-02-12 |
| 2022-12-13 | $8.24 10-K · filed 2024-09-18 | $1.03 10-Q · filed 2024-02-12 |
| 2019-06-30 | $2857143.00 10-K · filed 2019-09-12 | |
| 2017-10-31 | $16.70 10-K · filed 2020-09-10 | $1.67 10-Q · filed 2018-02-06 |
| 2015-06-30 | $2.50 10-K · filed 2017-09-07 | |
| 2012-09-19 | $4.00 10-K · filed 2015-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |